Clinical Trials Browser

Phase 1 × Interventional × Solid Tumors with FGFR2 Alterations, Adult × Clear all

NCT06800196 2025-01-29

A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors with FGFR2 Alterations

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumors with FGFR2 Alterations, Adult